# BNIP3L

## Overview
BNIP3L, also known as BCL2 interacting protein 3 like, is a gene that encodes a protein involved in the regulation of apoptosis and mitophagy. The protein, often referred to as NIX, is categorized as a mitophagy receptor due to its role in facilitating the selective degradation of mitochondria through autophagy. BNIP3L is characterized by a BH3 domain, which is crucial for its interaction with anti-apoptotic proteins such as Bcl-2 and Bcl-xL, and a C-terminal transmembrane domain that anchors it to the outer mitochondrial membrane (Imazu1999Bcl2E1B; Yasuda1998Adenovirus). This localization is essential for its function in mitochondrial quality control and cellular homeostasis. BNIP3L is involved in various physiological processes, including erythrocyte differentiation and hematopoietic homeostasis, and plays a significant role in pathological conditions such as cancer, neurodegenerative diseases, and ischemic brain injury (Chinnadurai2008BNIP3; Wu2020BNIP3LNIX).

## Structure
BNIP3L, also known as NIX, is a protein that plays a significant role in apoptosis and mitophagy. It contains a BH3 domain, which is essential for its pro-apoptotic activity and interaction with anti-apoptotic proteins such as Bcl-2 and Bcl-xL (Imazu1999Bcl2E1B; Yasuda1998Adenovirus). The protein also features a C-terminal transmembrane (TM) domain that anchors it to the outer mitochondrial membrane, facilitating its role in mitochondrial localization and dimerization (Marinković2020Dimerization; Yasuda1998Adenovirus).

BNIP3L forms stable homodimers, which are crucial for its function in mitophagy. The dimerization is mediated by a conserved GxxxG motif within the transmembrane domain, allowing lateral interactions between transmembrane alpha-helices (Marinković2020Dimerization). The protein is predominantly expressed as a 48-kDa dimer, indicating its quaternary structure (Marinković2020Dimerization).

Post-translational modifications, such as phosphorylation, regulate BNIP3L's activity. Specific serine residues, including S212, are phosphorylated, affecting dimerization and mitophagic activity (Marinković2020Dimerization; Li2021BNIP3LNIXmediated). These modifications play a role in the protein's ability to recruit autophagic machinery and initiate mitophagy (Marinković2020Dimerization).

## Function
BNIP3L, also known as BCL2 interacting protein 3 like, is a crucial player in the process of mitophagy, which is the selective degradation of mitochondria by autophagy. This protein acts as a mitophagy receptor, facilitating the recruitment of autophagosomes to mitochondria, thereby promoting the elimination of dysfunctional or excess mitochondria. This process is essential for maintaining mitochondrial quality and cellular homeostasis (Li2021BNIP3LNIXmediated).

BNIP3L is localized to the outer mitochondrial membrane, where it forms homodimers necessary for its mitophagic activity. The transmembrane (TM) domain of BNIP3L is critical for its mitochondrial distribution, while the LIR domain is essential for interaction with LC3 proteins, which are involved in autophagosome formation (Li2021BNIP3LNIXmediated).

In healthy human cells, BNIP3L is involved in erythrocyte differentiation and hematopoietic homeostasis. It plays a role in the clearance of mitochondria during the terminal stage of erythrocyte maturation, which is crucial for normal erythrocyte production and the maintenance of healthy cell function (Chinnadurai2008BNIP3).

## Clinical Significance
Mutations and alterations in the BNIP3L gene are implicated in various diseases, particularly those involving mitophagy and apoptosis. In the context of cerebral ischemia, BNIP3L degradation leads to mitophagy deficiency, resulting in the accumulation of damaged mitochondria, bioenergetic dysfunction, and neuronal inflammation. This deficiency can exacerbate ischemic brain injury, but interventions that prevent BNIP3L degradation can restore mitophagy and offer neuroprotection (Wu2020BNIP3LNIX).

In cancer, BNIP3L acts as a tumor suppressor, with its expression being crucial for p53-dependent apoptosis under hypoxic conditions. Loss of BNIP3L regulation can lead to reduced apoptosis and increased tumor growth, as seen in breast, ovarian, and lung cancers. BNIP3L's role in tumor suppression is highlighted by its ability to inhibit colony formation and induce apoptosis in cancer cell lines (Mellor2007The; Fei2004Bnip3L).

BNIP3L is also involved in neurodegenerative diseases such as Parkinson's disease, where its downregulation is linked to mitophagy defects. In amyotrophic lateral sclerosis, BNIP3L upregulation is observed, suggesting a role in disease pathogenesis (Li2021BNIP3LNIXmediated). These findings underscore BNIP3L's potential as a therapeutic target in conditions characterized by mitophagy deficiency and apoptosis dysregulation.

## Interactions
BNIP3L, also known as NIX, is a protein that interacts with several other proteins to regulate autophagy and apoptosis. It interacts with the anti-apoptotic proteins Bcl-2 and Bcl-xL through its BH3 domain, which is crucial for its pro-apoptotic activity. This interaction can alter mitochondrial membrane permeability, leading to apoptosis (Imazu1999Bcl2E1B). 

In the context of hypoxia-induced autophagy, BNIP3L disrupts the Bcl-2-Beclin1 complex, a key step in autophagy induction. The BH3 domains of BNIP3L compete with Beclin1 for binding to Bcl-2, promoting autophagy without inducing apoptosis due to their low affinity for Bcl-2 (Bellot2009HypoxiaInduced).

BNIP3L also plays a significant role in mitophagy, where it interacts with autophagosomal membrane-anchored proteins LC3 and GABARAP. Dimerization of BNIP3L enhances its affinity for these proteins, facilitating the recruitment of autophagic machinery necessary for mitochondrial clearance (Marinković2020Dimerization). The interaction with LC3 and GABARAP is mediated through the LIR motif, and phosphorylation near this motif is critical for receptor activation (Marinković2020Dimerization).


## References


[1. (Bellot2009HypoxiaInduced) Grégory Bellot, Raquel Garcia-Medina, Pierre Gounon, Johanna Chiche, Danièle Roux, Jacques Pouysségur, and Nathalie M. Mazure. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of bnip3 and bnip3l via their bh3 domains. Molecular and Cellular Biology, 29(10):2570–2581, May 2009. URL: http://dx.doi.org/10.1128/mcb.00166-09, doi:10.1128/mcb.00166-09. This article has 1142 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00166-09)

[2. (Li2021BNIP3LNIXmediated) Yue Li, Wanqing Zheng, Yangyang Lu, Yanrong Zheng, Ling Pan, Xiaoli Wu, Yang Yuan, Zhe Shen, Shijia Ma, Xingxian Zhang, Jiaying Wu, Zhong Chen, and Xiangnan Zhang. Bnip3l/nix-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death &amp; Disease, December 2021. URL: http://dx.doi.org/10.1038/s41419-021-04469-y, doi:10.1038/s41419-021-04469-y. This article has 65 citations.](https://doi.org/10.1038/s41419-021-04469-y)

[3. (Imazu1999Bcl2E1B) Tetsuo Imazu, Shigeomi Shimizu, Shinji Tagami, Mieko Matsushima, Yusuke Nakamura, Tsuneharu Miki, Akihiko Okuyama, and Yoshihide Tsujimoto. Bcl-2/e1b 19 kda-interacting protein 3-like protein (bnip3l) interacts with bcl-2/bcl-xl and induces apoptosis by altering mitochondrial membrane permeability. Oncogene, 18(32):4523–4529, August 1999. URL: http://dx.doi.org/10.1038/sj.onc.1202722, doi:10.1038/sj.onc.1202722. This article has 133 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1202722)

[4. (Fei2004Bnip3L) Peiwen Fei, Wenge Wang, Seok-hyun Kim, Shulin Wang, Timothy F. Burns, Joanna K. Sax, Monica Buzzai, David T. Dicker, W.Gillies McKenna, Eric J. Bernhard, and Wafik S. El-Deiry. Bnip3l is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell, 6(6):597–609, December 2004. URL: http://dx.doi.org/10.1016/j.ccr.2004.10.012, doi:10.1016/j.ccr.2004.10.012. This article has 177 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.ccr.2004.10.012)

[5. (Yasuda1998Adenovirus) Motoaki Yasuda, Paul Theodorakis, T. Subramanian, and G. Chinnadurai. Adenovirus e1b-19k/bcl-2 interacting protein bnip3 contains a bh3 domain and a mitochondrial targeting sequence. Journal of Biological Chemistry, 273(20):12415–12421, May 1998. URL: http://dx.doi.org/10.1074/jbc.273.20.12415, doi:10.1074/jbc.273.20.12415. This article has 180 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.20.12415)

[6. (Marinković2020Dimerization) Mija Marinković, Matilda Šprung, and Ivana Novak. Dimerization of mitophagy receptor bnip3l/nix is essential for recruitment of autophagic machinery. Autophagy, 17(5):1232–1243, April 2020. URL: http://dx.doi.org/10.1080/15548627.2020.1755120, doi:10.1080/15548627.2020.1755120. This article has 124 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2020.1755120)

[7. (Chinnadurai2008BNIP3) G Chinnadurai, S Vijayalingam, and S B Gibson. Bnip3 subfamily bh3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene, 27(S1):S114–S127, December 2008. URL: http://dx.doi.org/10.1038/onc.2009.49, doi:10.1038/onc.2009.49. This article has 159 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2009.49)

[8. (Wu2020BNIP3LNIX) Xiaoli Wu, Yanrong Zheng, Mengru Liu, Yue Li, Shijia Ma, Weidong Tang, Wenping Yan, Ming Cao, Wanqing Zheng, Lei Jiang, Jiaying Wu, Feng Han, Zhenghong Qin, Liang Fang, Weiwei Hu, Zhong Chen, and Xiangnan Zhang. Bnip3l/nix degradation leads to mitophagy deficiency in ischemic brains. Autophagy, 17(8):1934–1946, August 2020. URL: http://dx.doi.org/10.1080/15548627.2020.1802089, doi:10.1080/15548627.2020.1802089. This article has 86 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2020.1802089)

[9. (Mellor2007The) Howard R. Mellor and Adrian L. Harris. The role of the hypoxia-inducible bh3-only proteins bnip3 and bnip3l in cancer. Cancer and Metastasis Reviews, September 2007. URL: http://dx.doi.org/10.1007/s10555-007-9080-0, doi:10.1007/s10555-007-9080-0. This article has 90 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10555-007-9080-0)